| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |